Join
Live feed
·
INSIDERFilingvia Quantisnow
Interpace Biosciences, Inc. logo

Large owner Ampersand 2018 Limited Partnership converted options into 13,861,386 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
IDXG· Interpace Biosciences, Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track IDXG (Interpace Biosciences, Inc.) and more on Quantisnow.